To help illustrate the true threat of counterfeit and substandard medicines, and demonstrate why USP and so many other organizations are working to improve drug quality, we offer this first-hand story about two near-fatal encounters with bad drugs.
In Liberia, sellers of poor-quality medicines are capitalizing on public fears about Ebola. Learn what the Liberia Medicines and Health Products Regulatory Authority is doing about it and how the Promoting the Quality of Medicines Program--a collaborative effort between USAID and USP--is playing a role.
Mandela Washington Fellow, Dr. Ashiru Abubakar, talks with USP about the drug supply chain, the intersection of public health and political will, and the hope for a future free of counterfeit medicines in his native Nigeria.
PharmaChk, a user-friendly medicine quality detection device, is generating positive outcomes in field testing. Dr. Kennedy Chibwe, senior manager of the Promoting the Quality of Medicines program, explains how this technology may revolutionize the fight against counterfeit and substandard medicines in developing nations.
Tuberculosis (TB) is one of the world’s most prevalent diseases – it kills three people every minute. Although progress has been made in expanding access to treatment, the rate of multi-drug resistant TB cases has nearly doubled between 2011 and 2012. One factor driving drug resistance is poor quality drugs. Several global health organizations have partnered together to find a solution to ensure that safe and effective medicines are used in their treatment programs.